Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Contraception

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CONTRACEPTION.2004.12.017PMID 15792643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Injection of antiangiogenic agents into the macaque preovulatory follicle

  2007cited by this paper
• Local Delivery of Angiopoietin-2 into the Preovulatory Follicle Terminates the Menstrual Cycle in Rhesus Monkeys1

  2005cited by this paper
• Gonadotropin and Steroid Regulation of Matrix Metalloproteinases and Their Endogenous Tissue Inhibitors in the Developed Corpus Luteum of the Rhesus Monkey During the Menstrual Cycle1

  2004cited by this paper
• Changes in CD38 Expression and ADP-Ribosyl Cyclase Activity in Rat Myometrium During Pregnancy: Influence of Sex Steroid Hormones1

  2004cited by this paper
• The effect of angiogenesis inhibitor TNP-470 on the blood vessels of the lungs, kidneys and livers of treated hamsters.

  2004cited by this paper
• Regression of established tumors and metastases by potent vascular endothelial growth factor blockade

  2003cited by this paper
• Angiogenesis in the corpus luteum

  2003cited by this paper
• Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.

  2003cited by this paper
• Expression and localization of vascular endothelial growth factor and its receptors in pig corpora lutea during the oestrous cycle.

  2003cited by this paper
• Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria*

  2003cited by this paper
• I ntrabody‐based strategies for inhibition of vascular endothelial growth factor receptor‐2: effects on apoptosis, cell growth, and angiogenesis

  2003cited by this paper
• Changes of messenger RNAs encoding vascular endothelial growth factor and its receptors during the development and maintenance of caprine corpora lutea

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma

  2002cited by this paper
• Angiogenesis in the Corpus Luteum of Early Pregnancy in the Marmoset and the Effects of Vascular Endothelial Growth Factor Immunoneutralization on Establishment of Pregnancy

  2002cited by this paper
• A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

  2002cited by this paper
• Expression of Angiopoietin-1, Angiopoietin-2, and Tie2 Genes in Normal Ovary with Corpus luteum and in Ovarian Cancer

  2002cited by this paper
• Injection of Soluble Vascular Endothelial Growth Factor Receptor 1 into the Preovulatory Follicle Disrupts Ovulation and Subsequent Luteal Function in Rhesus Monkeys1

  2002influential reference
• Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.

  2001cited by this paper
• Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.

  2001cited by this paper
• Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor.

  2001cited by this paper
• Angiogenesis in the primate ovary.

  2001cited by this paper
• Identification of an angiogenic mitogen selective for endocrine gland endothelium

  2001cited by this paper
• Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40).

  2001cited by this paper
• Expression and Tissue Concentration of Vascular Endothelial Growth Factor, Its Receptors, and Localization in the Bovine Corpus Luteum During Estrous Cycle and Pregnancy1

  2000cited by this paper
• Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle.

  2000influential reference
• Angiogenesis in ovarian follicular and luteal development.

  2000cited by this paper
• Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody

  1999cited by this paper
• Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval.

  1999cited by this paper
• Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary.

  1998cited by this paper
• Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity

  1998cited by this paper
• Chronic treatment of female rhesus monkeys with low doses of the antiprogestin ZK 137 316: establishment of a regimen that permits normal menstrual cyclicity.

  1998cited by this paper
• Vascular endothelial growth factor is essential for corpus luteum angiogenesis

  1998cited by this paper
• Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells.

  1997cited by this paper
• Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.

  1997cited by this paper
• Signaling Vascular Morphogenesis and Maintenance

  1997influential reference
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997cited by this paper
• Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470

  1997cited by this paper
• Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture.

  1995cited by this paper
• Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle.

  1994cited by this paper
• Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).

  1994cited by this paper
• Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary.

  1992cited by this paper
• In vitro fertilization‐embryo transfer in nonhuman primates: The technique and its applications

  1990cited by this paper
• Changing frequency of pulsatile luteinizing hormone and progesterone secretion during the luteal phase of the menstrual cycle of rhesus monkeys.

  1984cited by this paper
• Hormonal profile after removal of the dominant follicle and corpus luteum in women.

  1983cited by this paper
• Follicle dominance and ovarian asymmetry after luteectomy in rhesus monkeys.

  1982cited by this paper
• Diurnal steroid patterns during gestation in the rhesus macaque: onset, daily variation, and the effects of dexamethasone treatment.

  1981cited by this paper
• Estrogens in fetal and maternal plasma of the rhesus monkey,.

  1975cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Angiogenesis in the Human Corpus Luteum: Localization and Changes in Angiopoietins, Tie-2, and Vascular Endothelial Growth Factor Messenger Ribo

  year unknowncited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society Differential Hormonal Regulation of Vascular Endothelial Growth Factors VEGF, VEGF-B, and VEGF-C Messenger Ribonucleic Acid Levels in Cultured Human

  year unknowncited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor*

  year unknowncited by this paper

• Classification of Human Ovarian Follicle Morphology: Recommendations of the NICHD-Sponsored Ovarian Nomenclature Workshop.

  2024cites this paper
• Microcystin-LR inhibits early pregnancy by impairing the vascular network of luteum: Involvement of the MEK/ERK/SP1/VEGFR2 axis.

  2022cites this paper
• Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis

  2022cites this paper
• Viral Infection of the Reproductive System in Times of COVID-19

  2022cites this paper
• Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study

  2022cites this paper
• The Inflammatory Cytokine Imbalance for Miscarriage, Pregnancy Loss and COVID-19 Pneumonia

  2022cites this paper
• Neurotensin: A novel mediator of ovulation?

  2021cites this paper
• Role of Vascular Endothelial Growth Factor (VEGF) in Human Embryo Implantation: Clinical Implications

  2021cites this paper
• Potential influence of COVID-19/ACE2 on the female reproductive system

  2020cites this paper
• OVULATION: Intra-ovarian mechanisms

  2019cites this paper
• Inflammation and angiogenesis in the corpus luteum

  2019cites this paper
• Ovulation: Parallels With Inflammatory Processes.

  2018cites this paper
• Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles

  2018cites this paper
• Ovulatory Induction of SCG2 in Human, Nonhuman Primate, and Rodent Granulosa Cells Stimulates Ovarian Angiogenesis.

  2018cites this paper
• Clinical Development of VEGF Signaling Pathway Inhibitors in Childhood Solid Tumors

  2017cites this paper
• Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys

  2017influential citation
• Vascular endothelial growth factors C and D may promote angiogenesis in the primate ovulatory follicle†

  2017cites this paper
• Angiogenesis in the Primate Ovulatory Follicle Is Stimulated by Luteinizing Hormone via Prostaglandin E21

  2015cites this paper
• Ovarian and oocyte targets for development of female contraceptives

  2015cites this paper
• Primate follicular development and oocyte maturation in vitro.

  2013cites this paper
• The development of tissue explant and embryonic stem cell derived models to investigate the molecular and cellular mechanisms that coordinate vertebrate haematopoiesis and angiogenesis

  2013influential citation
• Expression and regulation of ang-2 in murine ovaries during sexual maturation and development of corpus luteum

  2012cites this paper
• Differential Expression and Regulation of Angiopoietin-1 in Mouse Ovary during Sexual Maturation and Luteal Development

  2012cites this paper
• Expression of KIT in the ovary, and the role of somatic precursor cells.

  2011cites this paper
• Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.

  2011cites this paper
• Ovulation in the Absence of the Ovarian Surface Epithelium in the Primate1

  2010cites this paper
• Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K/AKT signaling pathway.

  2010cites this paper
• Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation.

  2010cites this paper
• Ovulation: A Molecular View

  2010cites this paper
• Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment.

  2009cites this paper
• Autocrine and Paracrine Regulation of the Ovary

  2009cites this paper
• Intrabursal Administration of the Antiangiopoietin 1 Antibody Produces a Delay in Rat Follicular Development Associated with an Increase in Ovarian Apoptosis Mediated by Changes in the Expression of BCL2 Related Genes1

  2008cites this paper
• Induction of proliferation in the primate ovarian surface epithelium in vivo.

  2008cites this paper
• Molecular mechanisms of ovulation: co-ordination through the cumulus complex.

  2007cites this paper
• Neutralization of Endogenous Vascular Endothelial Growth Factor Depletes Primordial Follicles in the Mouse Ovary1

  2007cites this paper
• Induction of proliferation in the primate ovarian surface epithelium in vivo

  2007cites this paper
• Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta).

  2007cites this paper
• Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle.

  2007cites this paper
• Molecular control of ovulation and luteinization in the primate follicle.

  2007cites this paper
• REVIEW ARTICLE ACCESSING MODERN CONTRACEPTIVE TECHNOLOGIES IN INDIA

  2006cites this paper
• Hormonal regulation and differential expression of neuropilin (NRP)-1 and NRP-2 genes in bovine granulosa cells.

  2006cites this paper
• Effect of a Vascular Endothelial Growth Factor (VEGF) Inhibitory Treatment on the Folliculogenesis and Ovarian Apoptosis in Gonadotropin-Treated Prepubertal Rats1

  2006cites this paper
• Neutralization of Endogenous VEGF Depletes Primordial Follicles in the Mouse Ovary. Short title: Neutralizing VEGF depletes primordial follicles. Summary sentence: Vascular Endothelial Growth Factor antibodies dramatically diminish the primordial follicle pool.

  2006cites this paper
• Accessing modern contraceptive technologies in India.

  2006cites this paper
• Circulating levels of total angiopoietin-2 and the soluble Tie-2 receptor in women during ovarian stimulation and early gestation.

  2006cites this paper
• Local Delivery of Angiopoietin-2 into the Preovulatory Follicle Terminates the Menstrual Cycle in Rhesus Monkeys1

  2005cites this paper